Form 483

Nature's Supplements, Inc. Form 483, 2023-04-05

FDA issued a Form 483 to Nature's Supplements, Inc. on 2023-04-05 with 7 public-safe observations.

483· Form 483 issuedFoods & Cosmetics7 observations

Nature's Supplements, Inc. · Oceanside, United States · Issued April 5, 2023

Overview

  • 7 public-safe observations are available for this inspection.
  • 7 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

5 Apr 2023
21 CFR 111.105(h)

Quality control - production, process control

Cited by Lilly O Barton

5 Apr 2023
21 CFR 111.120(b)

QC operations -specifications; components, packaging, labels

Cited by Lilly O Barton

5 Apr 2023
21 CFR 111.70(b)(1)

Specifications - component identity

Cited by Lilly O Barton

5 Apr 2023
21 CFR 111.70(b)(2)

Specifications-component purity, strength, composition

Cited by Lilly O Barton

5 Apr 2023
21 CFR 111.70(e)

Specifications - identity, purity, strength, composition

Cited by Lilly O Barton

Inspected site

NSNature's Supplements, Inc.Oceanside, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 111.105(h)Cited across public-safe Form 483 observations1x
21 CFR 111.120(b)Cited across public-safe Form 483 observations1x
21 CFR 111.70(b)(1)Cited across public-safe Form 483 observations1x
21 CFR 111.70(b)(2)Cited across public-safe Form 483 observations1x
21 CFR 111.70(e)Cited across public-safe Form 483 observations1x
21 CFR 111.75(a)(2)(ii)(A)Cited across public-safe Form 483 observations1x
21 CFR 111.75(h)(2)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 7 observations

The full inspection record, as Atlas holds it, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere